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Enzyme-linked immunospot: an alternative method for the detection of
interferon gamma in Johne’s disease
Douglas J. Begg,1 Kumudika de Silva, Katrina Bosward, Lyrissa Di Fiore, Deborah L. Taylor,
Gregers Jungersen, Richard J. Whittington
Abstract. To date, the sensitivity of the interferon gamma (IFN-c) enzyme-linked immunosorbent assay
(ELISA) to detect Johne’s disease (JD) has been poor, especially in the early stages of disease. To improve the
sensitivity of IFN-c detection in the early stages of infection, an alternate assay needs to be developed. The
enzyme-linked immunospot (ELISPOT) assay is a highly sensitive technique for the detection of cytokines and
has the potential to improve the diagnosis of JD. Of the variables examined, choice of capture antibody and
the method by which the peripheral blood mononuclear cells were isolated significantly affected the ability to
enumerate IFN-c–secreting cells. The ELISPOT assay was as sensitive as or better than the IFN-c ELISA at
detecting ovine JD and could also detect disease at early time points postinoculation. The IFN-c ELISPOT
could distinguish infected from unexposed animals; however, neither the IFN-c ELISA nor the ELISPOT
assay could distinguish between sheep experimentally infected with Mycobacterium avium subspecies
paratuberculosis and those exposed to the bacterium but diagnosed as uninfected at necropsy.
Key words: Enzyme-linked immunosorbent assay; enzyme-linked immunospot assay; interferon gamma;
Johne’s disease; paratuberculosis; sheep.
Introduction
Johne’s disease (JD) in ruminants is a chronic
enteritis caused by infection with Mycobacterium
avium subspecies paratuberculosis (MAP). The disease
is predominantly spread by the fecal-oral route, with
infection occurring in animals at a young age. In
sheep, clinical signs of the disease (weight loss and the
occasional case of diarrhea) develop from 2 to 5 years
of age. One of the confounding issues in the diagnosis
of ovine Johne’s disease (OJD) is the infecting strain
of MAP. There are 2 main strains of MAP: cattle (C)
and sheep (S). Typically, these infect their named host
species, but this is dependant on the geographical
location. For example, in sheep, the S strain is more
prevalent in Australia and New Zealand, while the C
strain is more common in India.34
Typically, it is difficult to diagnose JD in ruminants
during the early stages of the infection, as it is only
when the animals shed MAP into the environment
and clinical signs start to develop that the sensitivity
of the diagnostic tests improves. Current antemortem
testing for JD in sheep includes agar gel immunodif-
fusion, antibody enzyme-linked immunosorbent assay
(ELISA), fecal culture, and polymerase chain reaction
(PCR). Fecal culture is the current gold standard for
the identification of infected animals, although the S
strain has more fastidious culture requirements than
the C strain of MAP.42 An interferon gamma (IFN-c)
ELISA has also been evaluated, but as with the other
immunological diagnostic assays for MAP infection,
this has poor sensitivity in the early stages of infection
(Stewart DJ, Stiles PL, Whittington RJ, et al.: 2002,
Validation of the interferon-gamma for diagnosis of
ovine Johne’s disease: sensitivity and specificity field
trials. In: Seventh International Colloquium on
Paratuberculosis. International Association for Para-
tuberculosis, Bilbao, Spain).37
The traditional method for detection of IFN-c in
ruminants has been to stimulate whole blood
lymphocytes with MAP antigens, remove the plasma,
and carry out an ELISA on the plasma. Many
research groups typically use commercially available
kits for this type of test, such as the Bovigam assay.a
The detection of IFN-c for the diagnosis of JD using
this ELISA has had limited success, depending on the
animal species and the stage of disease. In sheep, the
Bovigam assay has low sensitivity, in the range of
50–75% (Stewart DJ, et al.: 2002, Validation of the
interferon-gamma for diagnosis of ovine Johne’s
disease).32 In cattle, IFN-c ELISAs have a high rate
of nonspecific reactions when detecting MAP infec-
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tion in animals younger than 24 months, due to
nonspecific IFN-c production by natural killer
cells,27,28 although this phenomenon has not been
observed in sheep.
In recent years, tuberculosis (TB) detection in
humans has improved through the use of IFN-c
assays based on the enzyme-linked immunospot
(ELISPOT) technique rather than traditional ap-
proaches such as intradermal skin tests.22 The ELI-
SPOT assay detects the number of IFN-c–producing
cells rather than the total amount of IFN-c as is
measured by traditional cytokine ELISA assays.
ELISPOT has been reported to be 10–200 times more
sensitive in the detection of cytokines than the
ELISA.38 In addition, the ELISPOT has been
developed as an alternative technology for diagnosing
TB, as it has the advantage of being able to
discriminate between different forms of TB, such as
latent or active infections.10 As these factors would
also be important in the diagnosis of JD, an IFN-c
ELISPOT was developed for the detection of MAP
infection in sheep. The ELISPOT was then compared
with IFN-c ELISA methods for the detection of
MAP-infected sheep.
Methods
Animals
All animals used in the current study were used
with the approval of the University of Sydney Animal
Ethics Committee. The Merino sheep (Ovis aries)
were maintained at pasture unless otherwise stated.
Vaccinated sheep. Two sheep were vaccinated with
a single dose of a vaccine for MAP subcutaneouslyb
(1 ml) to the anterior part of the neck as instructed by
the manufacturer.
Naturally exposed or JD-free sheep. Animals were
selected from farms in New South Wales, Australia,
on which OJD had been previously identified or
found to be free of the disease. The diseased animals
were transported to the University of Sydney OJD
quarantine facility and held for 2 weeks prior to
necropsy. The animals were fed lucerne chaff and
grain once daily with water supplied ad libitum. The
OJD-free property was identified by previous
monitoring in which 176 animals from the flock
were tested by pooled fecal culture40 and ELISA15
with negative results. All individuals also tested
negative for MAP in direct quantitative PCR
examination of feces20; 36 individuals in addition to
those used in the present trial were culled over a 2-
year period and found to be free of MAP infection by
culture and histopathology at necropsy. Sheep from
the OJD-free property were transferred to the
university on the day of the necropsy.
Experimentally infected sheep. Mycobacterium
avium subspecies paratuberculosis strain Telford 9.2,
a pure clonal culture at passage level 5 (including its
primary isolation from sheep feces), was reconstituted
from lyophilized stock and inoculated into a
BACTEC 12Bc vial supplemented with egg yolk and
mycobactin J (MJ).42 After culture in BACTEC to
achieve maximal growth, the vial was subcultured to
7H10+MJ42 slopes and incubated for 4–6 weeks at
37uC. Telford 9.2 is an IS1311 S strain, IS900
restriction fragment length polymorphism type
S1.25,26
The slopes were harvested and single-cell suspen-
sions prepared in phosphate buffered saline (PBS)
with 0.1% v/v Tween 80. Enumeration was by visual
counting in a Thoma-ruled counting chamber and by
end-point titration in BACTEC medium, using the
standard 3-tube most probable number (MPN)
method.31 The visual counts were used to prepare
the inocula at 109 MAP organisms/ml of undiluted
suspension. One-milliliter aliquots of this stock
suspension were diluted in 10 ml of PBS for each of
the animals to be infected, as shown in Table 1.
The remaining undiluted suspension (stock) was
retained at 4uC to repeat the inoculation 1 week later.
Another MPN was set up on the day of the second
dose from the stock suspension stored at 4uC to
confirm the viable dose after storage. IS900 and
IS1311 PCR assays conducted on the stock solution
were used to confirm that the infectious material was
MAP S strain. A fresh suspension was prepared for
the third inoculation dose, which was given to the
animals 1 month after the first dose.
Table 1. Experimental inoculations of Merino sheep.
Experiment Treatment
Age of animals at
challenge (months)
No. of
animals
First
dose*
Second
dose*
Third
dose*
Age at necropsy
(months)
1 Telford 9.2 3 18 9.3 3 106 9.3 3 106 2.4 3 108 14
2 Telford 9.2 4 20 9.3 3 107 9.3 3 107 1.5 3 108 13
2 Control 4 20 0 0 0 13
* The number of viable Mycobacterium avium subspecies paratuberculosis organisms given in each experimental inoculation dose per
animal. The second dose was delivered 1 week and the third dose 1 month after the first dose.
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Blood-sampling regimes
For comparisons of antibodies and preparation
methods for the ELISPOT, blood was taken as
required from the 2 vaccinated sheep. Blood samples
from OJD-free animals were taken either just prior to
necropsy or, in 1 experiment, at 12 months of age and
then again at 17 months of age, which was just prior
to necropsy. Naturally infected sheep were blood
sampled just prior to necropsy. Experimentally
infected sheep were sampled every 2–4 months until
necropsy.
Necropsy
All animals were euthanized using an intravenous
injection of barbiturate into the jugular vein. The
intestinal tract from the duodenum to the rectum was
removed from the animal and placed in a clean tray.
Between animals, the trays were cleaned with warm
water and Trigene 2d disinfectant. Samples were then
taken from the following sections of the small
intestine: terminal ileum and posterior, mid-distal,
middle, mid-proximal, and anterior jejunum. The
ileocecal lymph node and jejunal lymph nodes
corresponding to the sections of jejunum sampled
were also collected.
Histology
Tissue samples were placed in 10% buffered
formalin for 48–72 hr, embedded in paraffin, and
sectioned at 5 mm. Duplicate sections were stained
with hematoxylin and eosin or the Ziehl–Neelsen
stain. Sections were then graded using criteria
previously outlined.30 Any section graded with a
score of 1 or higher was considered to be positive for
OJD.
Isolation of MAP from feces and tissue
Samples were frozen at 280uC until they were
processed. Fecal and tissue samples were processed
for BACTEC culture as described previously.42
Briefly, after decontamination, samples were inocu-
lated into BACTEC vials and cultured for 12 weeks at
37uC. Culture-positive samples were then confirmed
by PCR and restriction enzyme analysis as previously
described.41,42
Purification of peripheral white blood cells
Ficoll density gradient centrifugation. A 10-ml
heparinized vacutainer of blood was centrifuged at
1,455 3 g for 20 min. The buffy coat of white blood
cells was removed, layered onto 2 ml of Ficoll-Paquee
(d 5 1.077), and centrifuged at 754 3 g for 30 min
with no brake. The cloudy layer of white blood cells
was removed and washed twice by centrifugation in
10 ml of PBS. The cells were resuspended in 5 ml of
10% fetal calf serumf made up in Roswell Park
Memorial Institute (RPMI)-1640f supplemented with
L-glutamine (2 mmol), 2-mercaptoethanol (58 mmol),
and penicillin/streptomycinf (100 m/ml; complete
media). The live cells were enumerated using Trypan
blue and suspended at 2.5 3 106 viable cells/ml.
Crude white blood cell buffy coat preparations. A
10-ml heparinized vacutainer of blood was
centrifuged at 1,455 3 g for 20 min. The buffy coat
of white blood cells was removed and washed twice by
centrifugation in 10 ml of PBS. The cells were
enumerated using Turk solution and resuspended in
complete media as stated above at 2.5 3 106 viable
cells/ml.
Red blood cell lysis. A 10-ml heparinized vacutainer
of blood was centrifuged at 1,455 3 g for 20 min. The
buffy coat of white blood cells was removed and placed
into 5 ml of red blood cell lysis buffer (NH4Cl 8.3 g,
KHCO3 1 g, ethylenediamine tetra-acetic acid 3.72 g,
and 10 mol of NaOH 0.4 ml in 1 liter of MQH20).
After a 5-min incubation at room temperature, 5 ml of
PBS was added to the buffy coat/lysis buffer mixture
and centrifuged at 233 3 g for 10 min. The cells were
washed with PBS before enumeration using Trypan
blue and resuspended in complete media as stated
above at 2.5 3 106 viable cells/ml.
ELISPOT assay to detect IFN-c
After optimization of the antibody concentrations
and examination of various substrates, the following
ELISPOT methodology was used in all assays unless
otherwise stated. ELISPOT platesg were coated with
50 ml of 2 mg/ml of a mouse monoclonal antibovine
IFN-c, either IFN6.19 (immunoglobulin G2a clone
6.19) or IFN-CC330 (Serotec, clone CC330) as
determined by the experiment, and incubated over-
night at 4uC. The plates were then hand washed 6
times with PBS to remove excess antibody. Purified
white blood cells at a concentration of 2.5 3 106 cells/
ml were diluted to concentrations of 1.25 3 106 cells/
ml and 6.25 3 105 cells/ml, with 100 ml of each
dilution being placed into adjacent wells as required
in all experiments. Fifty microliters of culture
medium, either alone (unstimulated) or with MAP
antigenh (316v, 30 mg/ml), and purified protein
derivative from M. aviumi (PPDA; 30 mg/ml) or
pokeweed mitogenj (PWM; 10 mg/ml) was added to
the wells. The plates were incubated for 18 to 24 hr at
37uC in air with 5% CO2.
At the end of the incubation, the plates were hand
washed 6 times using PBS to remove the cells, and
50 ml of the secondary antibody, a biotin-conjugated
mouse monoclonal antibovine IFN-c (clone CC302k),
was added at a concentration of 0.5 mg/ml diluted in
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PBS. The plates were then incubated at 37uC for 1 hr,
washed in PBS, and 50 ml of alkaline phosphatase
streptavidinl (1 mg/ml) diluted in PBS added. The
plates were then incubated at 37uC for 1 hr, washed 5
times in PBS, and 100 ml of 5-bromo-4-chloro-3-
indolyl phosphate (BCIP) substratel was added and
incubated for 1 hr at room temperature. The BCIP
substrate was then removed and the plate washed 6
times in tap water, then allowed to dry and read in a
KS ELISPOT reader.m
Results are presented as the number of antigen-
specific IFN-c–producing cells/105 white blood cells
by taking the number of antigen-reactive cells and
subtracting the number of unstimulated IFN-c–
producing cells/105 white blood cells. The test was
considered to be valid if the number of PWM-specific
IFN-c–producing cells/105 white blood cells was
greater than 15. Pokeweed mitogen stimulation was
used for initial monoclonal capture antibody testing
in the ELISPOT assay.
IFN-c ELISA
Blood stimulations. Heparinized blood (0.5 ml) was
placed into wells and stimulated with 0.5 ml of MAP
316v antigen at 20 mg/ml. The negative control
consisted of blood with 0.5 ml of culture medium,
while the positive control had 0.5 ml of media with
PWM added (10 mg/ml). After 48 hr of culture at
37uC in air supplemented with 5% CO2, the plasma
supernatant was collected and stored at 220uC.
Bovigam ELISA.a An analysis of IFN-c was
performed using the standard protocol outlined for
the Bovigam ELISA kit. Results are presented as the
optical density (OD) of the MAP antigen-stimulated
sample – the OD of the negative control (medium-
stimulated) sample.
In-house IFN-c ELISA. ELISA platesn were coated
with 50 ml of 1.5 mg/ml mouse monoclonal anti–
IFN-c antibody (IFN 6.19) and incubated overnight
at 4uC. Frozen plasma supernatant samples were
thawed and brought to room temperature. The plates
were machine washed 5 times using wash buffer (PBS
with 0.05% Tween 20) prior to adding 50 ml of PBS to
appropriate wells followed by 50 ml of the plasma
supernatant sample. The plates were incubated at
room temperature for 1 hr and then washed 5 times
using wash buffer. The secondary antibody (mouse
monoclonal anti–IFN-c antibody biotin-conjugated
clone CC302; 50 ml) was added at a concentration of
0.5 mg/ml diluted in PBS. The plates were incubated
at room temperature for 1 hr and then machine
washed 5 times using wash buffer. Fifty ml of
horseradish peroxidase–streptavidinl was added
(0.01 mg/ml in PBS). The plates were incubated at
room temperature for 1 hr and machine washed 5 times
using wash buffer. TMB (3,39,5,59-tetramethylbenzidine)
substrateo (100 ml) was added to each well as required,
and the plate was incubated in the dark for 30 min. The
reaction was then stopped with 100 ml of 2 mol
sulphuric acid. The OD was measured in an ELISA
readerp at 450 nm. Results are presented as the OD of
the MAP antigen-stimulated sample – the OD of the
medium-stimulated sample.
Results
Comparisons of antibodies and preparation methods
for ELISPOT
After the initial antibody concentration optimiza-
tion, the sensitivity of detecting spots in the IFN-c
ELISPOT assay was found to be affected by several
parameters. These included the choice of capture
antibody and the method of isolating the white blood
cells. The ELISPOT reader was optimized for
counting spots from the IFN-c ELISPOT assay using
the IFN-CC330 capture antibody. The same settings
were used to compare the 2 capture antibodies (IFN-
CC330 and IFN6.19) and the different white blood
cell isolation methods.
In a direct comparison of the 2 capture antibodies,
on average 6-fold more spots were resolved with
IFN6.19 compared with IFN-CC330, measured
across a range of test conditions including antigen-
and mitogen-stimulated cells from various sheep. The
difference was highly significant (paired t-test P ,
0.001), with spots being more pronounced when using
the IFN6.19 antibody, which enabled the ELISPOT
reader to detect them more readily.
The initial optimization of the IFN-c ELISPOT
assay was completed on peripheral blood mono-
nuclear cells (PBMC) isolated using Ficoll-Paque
density gradient centrifugation. This was the standard
method to which the red blood cell lysis buffer and
crude white blood cell buffy coat isolation methods
were compared. The effect of the cell isolation
method was compared using both the IFN-CC330
and IFN6.19 capture antibodies, as shown in Table 2.
Both red blood cell lysis and crude buffy coat
methods produced significantly fewer spots than the
Ficoll isolation method regardless of the capture
antibodies used (Table 2). Wells containing buffy
coat–prepared cells had a red-brown tinge in the
center due to red blood cell contamination, with
increased background color when higher concentra-
tions of cells were used (Fig. 1). When cells were
prepared by red blood cell lysis, there was no
background color, but there were fewer spots across
the range of cell dilutions tested (Fig. 1). The Ficoll
isolation method was therefore used for subsequent
experimental trials.
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OJD-free animals
A group of 10 Merino ewes older than 3 years were
selected from a farm shown to be free of MAP. The
10 animals tested negative for OJD by histological
analysis and culture of MAP from their intestinal
tissues. Although these animals were classified as
OJD negative, 7 of the 10 animals had MAP-specific
responses in the range of 1 to 10 reactive cells per 105
white blood cells (Fig. 2). However, 6 of the 10
animals had a stronger response to PPDA than to
MAP antigen. Using these data, a preliminary cut
point of 10 MAP reactive cells per 105 white blood
cells was used to identify strong responders in the
remainder of the study.
In another experiment, MAP antigen–specific
responses in animals not exposed to MAP were
compared over time. Figure 3 shows the change in
MAP antigen–specific responses from a group of 20
uninfected animals from 12 to 17 months of age using
the IFN-c ELISPOT and ELISA. The sheep were
later confirmed to be free of infection through tissue
culture and histological analysis. While 11 of the
animals consistently had low numbers of MAP
antigen–specific cells over this time period, 9 animals
had an increasing number; however, this increase was
not significant (paired t-test). The in-house IFN-c
ELISA showed that most animals had an antigen-
Figure 1. Images of the spots produced when using different
white blood cell purification procedures. The capture antibody
IFN-CC330 was used, while Ficoll-Paque density gradient centri-
fugation, isolation of the buffy coat via centrifugation, or lysis of
the red blood cells from buffy coat preparations was used to purify
the cells. All cells were stimulated with pokeweed mitogen.
Table 2. Effect of mononuclear blood cell isolation method on the outcome in the ovine interferon gamma (IFN-c) enzyme-linked
immunospot (ELISPOT) assay for 2 different anti–IFN-c capture antibodies.
Capture antibody: IFN-CC330
No. of spots observed % reduction
from Ficoll
isolation method*
No. of spots observed % reduction
from Ficoll
isolation method*Crude buffy coats Ficoll isolation Red blood cell lysis method Ficoll isolation
1.6 40 96 31 90 65
3.2 56 94 36 186 81
56 113.6 51 30 131 77
12.8 36.8 65 63 134 53
Average % decrease 77 69
Paired t-test{ P , 0.01 P , 0.01
Capture antibody: IFN6.19
No. of spots observed % reduction
from Ficoll
isolation method*
No. of spots observed % reduction
from Ficoll
isolation method*Crude buffy coats Ficoll isolation Red blood cell lysis method Ficoll isolation
97 299 68 145 320 55
70 278 75 134 328 59
6 160 96 131 240 45
15 150 90 98 235 59
Average % decrease 82 54
Paired t-test P , 0.005 P , 0.005
* The percentage decrease in the number of spots enumerated from the IFN-c ELISPOT was calculated using matching results
gathered from the Ficoll and alternative (red blood cell lysis and crude buffy coats) white blood cell isolation methods. All cells were
stimulated with pokeweed mitogen.
{ Significance of the decrease in number of spots enumerated from the IFN-c ELISPOT using the alternative (red blood cell lysis and
crude buffy coats) white blood cell isolation methods from that of the Ficoll isolation method was calculated using a paired t-test.
IFN-c ELISPOT to detect Johne’s disease 191
specific change of less than 0.1 OD. The average
change for both assays over time was nonsignificant.
Diagnosis of naturally infected animals
A group of animals from a farm found previously
to have sheep with OJD were tested. The IFN-c
ELISPOT assay detected strong cytokine production
(.10 MAP antigen–specific IFN-c–producing cells
per 105 white blood cells) from 8 of 10 MAP culture–
positive animals. The 2 IFN-c assays gave different
results in 5 of the animals: sheep nos. 981, 986, 990,
and 993 were strong responders in the ELISPOT only
(Table 3). Sheep no. 981, which was MAP culture
negative, also had a strong IFN-c ELISPOT response
(Table 3). The remaining 3 MAP tissue culture–
negative animals had minimal IFN-c responses in
both the ELISPOT and Bovigam ELISA assays.
Longitudinal study of experimentally infected animals
Sheep experimentally inoculated, using a standard-
ized infection model, with a clonal strain of MAP
were monitored until the first signs of clinical disease
developed in the flocks. MAP-specific IFN-c–pro-
ducing cells were detected by ELISPOT as early as 3
months postinoculation. The strength of this response
varied over time and between the different experi-
mental infection trials (Fig. 4A, 4C). Sampling of
experimentally infected animals over time consistently
showed that sheep inoculated with MAP had more
antigen-specific IFN-c–producing cells than uninoc-
ulated control animals (Fig. 4C).
Results from the MAP-specific in-house IFN-c
ELISA on the experimentally infected animals in trial
1 resembled the profile of the ELISPOT assay
(Fig. 4A, 4B). In trial 2, the IFN-c profiles of the 2
assays varied over time (Fig. 4C, 4D). The ELISA
assay suggested progressively increasing total IFN-c
levels, while the ELISPOT assay detected higher
responses in the infected sheep at necropsy. A drop in
IFN-c–producing cells was seen between 4 and 8
months postinoculation by ELISPOT that was not
evident by ELISA. In trial 2, the ELISPOT assay was
able to distinguish between tissue culture–positive and
–negative animals at necropsy.
Discussion
Results from the current study demonstrate for the
first time the use of an IFN-c ELISPOT assay applied
to the diagnosis of JD in ruminants. Results from
these experiments indicate that using the IFN-c
Figure 2. Interferon gamma (IFN-c) enzyme-linked immu-
nospot (ELISPOT) assay responses from ovine Johne’s disease
(OJD)-free sheep. Peripheral blood mononuclear cells (PBMC)
were isolated from 10 sheep older than 3 years. The animals were
found to be free of OJD by histological analysis and tissue culture
of intestinal tissues. The assay used the IFN6.19 capture antibody
and shows the antigen-specific responses to Mycobacterium avium
subspecies paratuberculosis (MAP) and purified protein derivative
from Mycobacterium avium (PPDA). The PBMC were isolated via
Ficoll density gradient centrifugation. The dotted line indicates an
arbitrary cutoff at which animals are considered to have a strong
response to the MAP antigen.
Figure 3. Change in Mycobacterium avium subspecies para-
tuberculosis–specific interferon gamma (IFN-c) responses in ovine
Johne’s disease–free sheep using an enzyme-linked immunospot
(ELISPOT) assay and enzyme-linked immunosorbent assay
(ELISA). Twenty sheep were monitored from 12 to 17 months.
A, IFN-c ELISPOT assay. Individual animals are shown along the
x-axis. The capture antibody used was IFN6.19, and peripheral
blood mononuclear cells (PBMC) were isolated via Ficoll density
gradient centrifugation. B, in-house IFN-c ELISA. Av*5 average
change over the 20 animals from 12 to 17 months of age in the
number of IFN-c–producing cells (A) or antigen-specific optical
density (OD) reading (B).
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ELISPOT assay to detect MAP-infected sheep may
provide a method as sensitive as or more sensitive
than the traditional IFN-c ELISA.
Important aspects that affect an ELISPOT assay
include the affinity of the capture and detection
antibodies, the activity of the enzyme conjugates, and
the substrates used to generate the spots.19 While
there are a limited number of reagents available to
veterinary researchers, 3 antibovine mouse monoclo-
nal antibodies were found to be cross-reactive to
ovine IFN-c. Only 1 of the antibodies was commer-
cially biotin conjugated (clone CC302), and this
enabled evaluation of 2 different capture antibodies
(IFN6.19 and IFN-CC330). As stated previously,19
the darker the spots and the lighter the background,
the more accurate the quantification. The IFN6.19
monoclonal antibody was selected as the optimal
capture antibody as it produced superior spots and
improved quantification, possibly due to this anti-
body’s having a higher affinity for ovine IFN-c.
The method by which the PBMC were prepared
was also important. This method was assessed
because possible future development of the assay will
require high throughput and low cost. Ficoll-Paque
density gradient centrifugation produced the most
Table 3. Interferon gamma (IFN-c) results and infection status
as shown by Mycobacterium avium subspecies paratuberculosis
(MAP) tissue culture and histology from a group of animals from
a farm known to be infected with ovine Johne’s disease.*
Animal no. ELISPOT{ Bovigam{ Culture Histology
988 60.8 2.830 + +
993 37.6 0.047 + 2
985 27.6 1.904 + +
990 25.6 0.147 + +
992 22.8 1.295 + +
995 22.8 0.529 + 2
994 11.2 1.821 + +
986 11.2 0.000 + +
989 2.4 2.790 + +
987 0.4 0.152 + 2
981 33.2 0.061 2 2
996 4.4 0.066 2 2
984 3.6 0.007 2 2
991 0.8 0.000 2 2
* ELISPOT 5 enzyme-linked immunospot assay; + 5 positive;
2 5 negative.
{ Number of MAP antigen–specific IFN-c–reactive cells/105
white blood cells using the capture antibody IFN-CC330. The
cells were isolated using Ficoll density gradient centrifugation.
{ The MAP antigen–specific IFN-c enzyme-linked immunosor-
bent assay optical density reading from whole-blood samples
tested using the Bovigam assay.
Figure 4. Mycobacterium avium subspecies paratuberculosis (MAP)–specific interferon gamma (IFN-c) enzyme-linked immuno-
spot (ELISPOT) assay responses from experimentally infected animals over time. A, average IFN-c ELISPOT assay responses and B,
average in-house IFN-c enzyme-linked immunosorbent assay (ELISA) responses from animals inoculated in experiment 1 that were
tissue culture positive or negative. C, average IFN-c ELISPOT assay responses and D, average in-house IFN-c ELISA responses from
animals inoculated in experiment 2 that were tissue culture positive or negative, and a group of animals not exposed to MAP. Necropsy
occurred at 13 months postinoculation. Error bars indicate the standard error of the mean. OD 5 optical density.
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easily measured spots by the KS ELISPOT reader.
Red blood cell lysis of buffy coat also gave well-
defined spots, although fewer of them. Unfortunately,
the easiest cell separation method examined, crude
buffy coats, led to increased nonspecific background
noise, and fewer spots were enumerated. A reduction
in the number of spots when using the red blood cell
lysis and buffy coat methods compared with Ficoll
separation was not unexpected, as the latter removes
most of the granulocytes, leading to the enrichment of
the mononuclear cell population that produce IFN-c.
Neutrophils comprise 10–50%, eosinophils 0–10%,
and basophils 0–3% of the total leucocyte population
in sheep blood.13 The IFN-c–producing cells are most
likely to be T cells,2,36 so granulocytes dilute the
number of IFN-c–producing cells, resulting in fewer
spots being recorded. While it may be possible to
increase the number of cells added to increase the
sensitivity from the red blood cell lysis and buffy coat
methods, this may result in increased nonspecific
background noise.
The number of MAP-specific IFN-c–reactive cells
in sheep infected with MAP appears to be very low, in
the range of 10 to 100 IFN-c–producing cells per 105
white blood cells. Differences between the 2 methods
may be due to few cells producing large amounts of
IFN-c, and this could be an indication of disease
status. Previous studies showed that as cattle and
sheep move from subclinical to clinical JD, there is
typically a drop in the cell-mediated immune
response,21,35 although in sheep, the IFN-c response
does not always decline.3 As fewer cells may produce
IFN-c but at a higher level per cell, there may be a
role for assays that measure total IFN-c as well as the
number of IFN-c–producing cells. The cutoff value to
determine uninfected from infected animals needs to
be examined in more detail with larger numbers of
animals.
The difference between the different types of IFN-c
assays (ELISA and ELISPOT) in identifying animals
as being low or high IFN-c responders (Table 3,
Fig. 4) was not surprising and may aid further
discrimination of diseased animals. The assays
measure different outputs (the total amount of IFN-c
released into the plasma for the ELISA compared
with the total number of IFN-c–secreting cells
measured in the ELISPOT). The different assay
outputs could be used as part of an improved array
of diagnostic assays to diagnose JD in the early stages
of subclinical infection.
One sheep (no. 981; Table 3) that had been
exposed to MAP naturally had a high number of
MAP IFN-c–producing cells, but this animal was
negative by tissue culture and histology and, as such,
apparently free of infection. This response can be
explained from observations made in experimentally
infected sheep. Animals that are inoculated with
MAP may overcome the infection.4,5,16,39 Exposed
animals that had negative culture results from tissues
(Fig. 4) have possibly eliminated the bacteria or are
controlling the infection to a level lower than can be
detected by microbiological culture of tissue. In trial
2, the number of MAP-specific IFN-c–producing cells
in animals with no detectable infection at 13 to 14
months after inoculation was higher than in the
unexposed controls but lower than that of sheep with
active infection at the time of necropsy. This indicates
that in its current form, the IFN-c ELISPOT assay
provides evidence of exposure and may have the
potential to discriminate active from past infection.
Unexposed sheep with no evidence of MAP
infection by histology or tissue culture had low levels
of MAP antigen–specific IFN-c–producing cells. In
general, these animals had a larger number of M.
avium–specific cells per 105 white blood cells. This
could be an indication of exposure to environmental
mycobacteria and the poor specificity of the MAP
antigen used. The use of crude antigens has been
identified as a problem for the immunological
diagnosis of JD in many studies.1,7–9,23,24,43 There is
a need for defined specific antigens that could enable
extension of the assay to identify animals likely to be
immune and those with a latent infection that will
eventually succumb to disease. It may enable identi-
fication of sheep that go on to develop a specific
lesion type. Research carried out on TB has shown
that specific antigens such as region of difference 1
(RD1) including culture filtrate protein 10, early
secreted target 6, and other proteins such as Rv2031c
(also known as HspX, alpha crystalline, or the 16-
kDa antigen) used in an IFN-c ELISPOT tests can
differentiate between active and latent TB patients
and people who have been vaccinated with Bacillus
Calmette-Gue´rin.10,11,14,22 However, the use of a single
RD1 antigen resulted in a high degree of specificity
but low sensitivity. Improved results are seen when
multiple RD1 antigens are used.29 Numerous studies
have been carried out to identify new antigens that
may be used in the currently available and new MAP
immunodiagnostic tests.1,7–9,17,23,24 To date, these
recently identified antigens have examined only
humoral and not cell-mediated immune responses.
There are a number of documented technical
concerns related to the use of ELISPOT assays.
These include interoperator variation, especially with
regard to the enumeration of the cytokine-secreting
cells and the handling of blood samples. Interopera-
tor variation was overcome in these studies by using a
standardized protocol, assay-specific controls, a
standard automated ELISPOT reader, and software
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parameters.18,33 Other issues relating to blood sample
handling apply to both the traditional IFN-c ELISA
and the ELISPOT assays and result in a reduction of
the signal. Issues include the interval between blood
collection and processing and the storage temperature
of blood. The addition of stabilization reagents to the
blood tube at sampling12 or the addition of certain
cytokines or antibodies at the time of stimulation
(Jungersen G, Grell SN, Clemensen A, Howard CJ:
2005, Interleukin-12 potentiation of the interferon-
gamma test rescues day old blood samples for
diagnosis of paratuberculosis PPD specific cellular
mediated immune responses. 8th International Col-
loquium on Paratuberculosis. Copenhagen, Den-
mark)6 may overcome this problem. These refine-
ments can be investigated in the ELISPOT assay for
MAP.
The IFN-c ELISPOT assay has the potential to
improve the diagnosis of JD in animals, as shown in
the current study. The assay can detect infected
animals at a similar or better rate than the IFN-c
ELISA. This is the first successful application of an
IFN-c ELISPOT assay to detect naturally and
experimentally MAP-infected ruminants. The ELI-
SPOT assay could be an important tool as part of a
diagnostic assay array to provide increased informa-
tion on an animal’s disease status. Investigations
comparing the traditional IFN-c ELISA with the
ELISPOT assay and other methods of detecting
cytokines are warranted.
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